Owner Genentech, Inc.

Inventors Wu, Thomas D.; Cairns, Belinda; Frantz, Gretchen; Polakis, Paul; Zhang, Zemin; Koeppen, Hartmut; Williams, P. Michkey; Phillips, Heidi S.; Hillan, Kenneth J.; Chen, Ruihuan; Spenser, Susan D.; Smith, Victoria

Agent Griffith Hack

Pub. Number AU-B-2009200399

Parent 2006203137

Filing date 3 February 2009

Wipo publication date 26 February 2009

Acceptance publication date 24 May 2012

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies